These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2597534)

  • 1. Platelet interactions with heparin binding growth factor and fibronectin.
    Greisler HP; Klosak JJ; Steinam S; Burgess WH; Henderson SC; Cabusao EA; Ellinger J
    ASAIO Trans; 1989; 35(3):561-3. PubMed ID: 2597534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of class I heparin binding growth factor and fibronectin on platelet adhesion and aggregation.
    Greisler HP; Klosak JJ; Steinam SJ; Lam TM; Burgess WH; Kim DU
    J Vasc Surg; 1990 May; 11(5):665-74. PubMed ID: 1692352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombogenicity of a fibronectin-coated, experimental polytetrafluoroethylene graft.
    Kempczinski RF; Ramalanjaona GR; Douville C; Silberstein EB
    Surgery; 1987 Apr; 101(4):439-44. PubMed ID: 3563890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin glue containing fibroblast growth factor type 1 and heparin decreases platelet deposition.
    Zarge JI; Husak V; Huang P; Greisler HP
    Am J Surg; 1997 Aug; 174(2):188-92. PubMed ID: 9293842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-binding growth factor-I (endothelial cell growth factor) binds to endothelium in vivo.
    Rosengart TK; Kupferschmid JP; Ferrans VJ; Casscells W; Maciag T; Clark RE
    J Vasc Surg; 1988 Feb; 7(2):311-7. PubMed ID: 2448501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet deposition on ePTFE grafts coated with fibrin glue with or without FGF-1 and heparin.
    Zarge JI; Gosselin C; Huang P; Vorp DA; Severyn DA; Greisler HP
    J Surg Res; 1997 Jan; 67(1):4-8. PubMed ID: 9070173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
    Laredo J; Xue L; Husak VA; Ellinger J; Greisler HP
    Am J Surg; 2003 Nov; 186(5):556-60. PubMed ID: 14599625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo platelet deposition on polytetrafluoroethylene coated with fibrin glue containing fibroblast growth factor 1 and heparin in a canine model.
    Gosselin C; Ren D; Ellinger J; Greisler HP
    Am J Surg; 1995 Aug; 170(2):126-30. PubMed ID: 7543261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
    Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP
    J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally produced extracellular matrix is an excellent substrate for canine endothelial cell proliferation and resistance to shear stress on PTFE vascular grafts.
    Schneider A; Chandra M; Lazarovici G; Vlodavsky I; Merin G; Uretzky G; Borman JB; Schwalb H
    Thromb Haemost; 1997 Nov; 78(5):1392-8. PubMed ID: 9408025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ePTFE coating with fibrin glue, FGF-1, and heparin: effect on retention of seeded endothelial cells.
    Gosselin C; Vorp DA; Warty V; Severyn DA; Dick EK; Borovetz HS; Greisler HP
    J Surg Res; 1996 Feb; 60(2):327-32. PubMed ID: 8598663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-bonded grafts induce platelet aggregation in the presence of heparin-associated antiplatelet antibodies.
    Almeida JI; Liem TK; Silver D
    J Vasc Surg; 1998 May; 27(5):896-900; discussion 900-1. PubMed ID: 9620142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin, not laminin, mediates heparin-dependent heparin-binding growth factor type I binding to substrata and stimulation of endothelial cell growth.
    Kan M; Shi EG
    In Vitro Cell Dev Biol; 1990 Dec; 26(12):1151-6. PubMed ID: 1706698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inferior vena cava replacement: the role of antiplatelet therapy.
    Lovaas ME; Gloviczki P; Dewanjee MK; Hollier LH; Kaye MP
    J Surg Res; 1983 Sep; 35(3):234-42. PubMed ID: 6887844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor).
    Winkles JA; Friesel R; Burgess WH; Howk R; Mehlman T; Weinstein R; Maciag T
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7124-8. PubMed ID: 2444975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and distribution of heparin-binding growth factor I (endothelial cell growth factor) in the rat.
    Rosengart TK; Kuperschmid JP; Maciag T; Clark RE
    Circ Res; 1989 Feb; 64(2):227-34. PubMed ID: 2463884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between fibronectin and Matrigel pretreated ePTFE vascular grafts.
    Patterson RB; Keller JD; Silberstein EB; Kempczinski RF
    Ann Vasc Surg; 1989 Apr; 3(2):160-6. PubMed ID: 2765358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.
    Mioh H; Chen JK
    J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment.
    Greisler HP; Cziperle DJ; Kim DU; Garfield JD; Petsikas D; Murchan PM; Applegren EO; Drohan W; Burgess WH
    Surgery; 1992 Aug; 112(2):244-54; discussion 254-5. PubMed ID: 1641764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute thrombogenicity of arterial prostheses exposed to reduced blood flow in dogs: effects of heparin, aspirin, and prostacyclin.
    Merhi Y; Bernier J; Marois Y; Guidoin R
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):1-5. PubMed ID: 7564348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.